Cargando…
Ixekizumab successfully treated severe pityriasis rubra pilaris after COVID‐19 vaccination
Pityriasis rubra pilaris is an inflammatory dermatologic disorder of unknown cause. We report a 67‐year‐old man with Pityriasis rubra pilaris might induced by COVID‐19 vaccination. The patient developed the lesions after the first dose of vaccine and significantly aggravated after the second dose. H...
Autores principales: | Liu, Ya‐ting, Wang, Shang‐shang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349810/ https://www.ncbi.nlm.nih.gov/pubmed/35941937 http://dx.doi.org/10.1002/ski2.139 |
Ejemplares similares
-
Successful Treatment of Pityriasis Rubra Pilaris with Ixekizumab
por: Hanfstingl, Kathrin, et al.
Publicado: (2018) -
Pityriasis rubra pilaris following COVID-19 vaccination successfully treated with ixekizumab
por: Zhao, Patricia, et al.
Publicado: (2023) -
Successful treatment of type I pityriasis rubra pilaris with ixekizumab
por: Heibel, Mark D., et al.
Publicado: (2018) -
Pityriasis rubra pilaris rapidly cleared with ixekizumab in an HIV-positive patient
por: Kranyak, Allison, et al.
Publicado: (2022) -
Kaposi’s Varicelliform Eruption After Treatment With Ixekizumab in a Patient With Pityriasis Rubra Pilaris
por: Guenther, Jana S, et al.
Publicado: (2023)